ES2127133B1 - USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE. - Google Patents

USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE.

Info

Publication number
ES2127133B1
ES2127133B1 ES9700827A ES9700827A ES2127133B1 ES 2127133 B1 ES2127133 B1 ES 2127133B1 ES 9700827 A ES9700827 A ES 9700827A ES 9700827 A ES9700827 A ES 9700827A ES 2127133 B1 ES2127133 B1 ES 2127133B1
Authority
ES
Spain
Prior art keywords
derivatives
manufacture
prevention
treatment
dihydroxybenzenosphone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9700827A
Other languages
Spanish (es)
Other versions
ES2127133A1 (en
Inventor
Soler Jose Esteve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2127133A1 publication Critical patent/ES2127133A1/en
Application granted granted Critical
Publication of ES2127133B1 publication Critical patent/ES2127133B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Utilización de derivados 2,5-dihidroxibencenosulfónicos para la fabricación de medicamentos destinados al tratamiento y a la prevención de la enfermedad de Alzheimer. Utilización de derivados 2,5-dihidroxibencenosulfónicos de fórmula general I, en la cual: R representa H o SO{sup,- {sub,3 ; B representa Ca{sup,++ o H{sub,2 N{sup,+ (C{sub,2 H{sub,5 ){sub,2 ; n representa 1 ó 2; y m representa 1 ó 2, para la fabricación de medicamentos destinados a prevenir la formación de la proteína amiloide asociada a la enfermedad de Alzheimer.Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of drugs for the treatment and prevention of Alzheimer's disease. Use of 2,5-dihydroxybenzenesulfonic derivatives of general formula I, in which: R represents H or SO {sup, - {sub, 3; B represents Ca {sup, ++ or H {sub, 2 N {sup, + (C {sub, 2 H {sub, 5) {sub, 2; n represents 1 or 2; and m represents 1 or 2, for the manufacture of drugs intended to prevent the formation of the amyloid protein associated with Alzheimer's disease.

ES9700827A 1996-04-03 1997-04-03 USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE. Expired - Fee Related ES2127133B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604181 1996-04-03

Publications (2)

Publication Number Publication Date
ES2127133A1 ES2127133A1 (en) 1999-04-01
ES2127133B1 true ES2127133B1 (en) 1999-12-01

Family

ID=9490864

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9700827A Expired - Fee Related ES2127133B1 (en) 1996-04-03 1997-04-03 USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE.

Country Status (1)

Country Link
ES (1) ES2127133B1 (en)

Also Published As

Publication number Publication date
ES2127133A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
DE68916693T2 (en) Molecular diagnosis of Alzheimer's disease.
ES2170104T3 (en) INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS.
HUP9700603A1 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
DK1056856T3 (en) Modified ciliary neurotrophic factor and methods for its formation and use
DK678887D0 (en) PHARMACEUTICAL PREPARATIONS
DE3679920D1 (en) SPIRO-3-HETEROAZOLIDINE COMPOUNDS AND THEIR SALTS, THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM.
ATE162075T1 (en) COMBINATION PHARMACEUTICAL PREPARATION CONTAINING A URICOSURIC AGENT AND AN EXCITATORY AMINO ACID ANTAGONIST
IT8322855A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
PT998287E (en) USES OF LEVOBUPIVACAINE
DE69201660D1 (en) Use of acetyl L-carnitine for the therapeutic treatment of coma.
TR200000455T2 (en) The use of fanquinone in the treatment of Alzheimer's disease.
IT8721115A0 (en) PHYTO-PREPARATION FOR THE TREATMENT OF SKIN DISEASES.
DE69621786T2 (en) AMINOTETRAL IN DERIVATIVE FOR THE TREATMENT OF HEART CIRCULAR DISEASE
ES2127133B1 (en) USE OF 2,5-DIHYDROXYBENZENOSPHONE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT AND PREVENTION OF ALZHEIMER DISEASE.
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
NO971453D0 (en) Use of bradykinin antagonists in the manufacture of drugs for the treatment of chronic fibrogenetic and acute liver diseases
LV11524A (en) Use of benzidamine as a treatment for pathological conditions induced by TNF
HUP0102116A2 (en) Paroxetine ascorbate, process for its preparation and its pharmaceutical use
SE8802323D0 (en) 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IT8919216A0 (en) DEVICE FOR THE SURGICAL TREATMENT OF ASTIGMATISM.
DE68914886T2 (en) Agent for the treatment of Raynaud's disease.
IT9048106A0 (en) MEDICINAL ASSOCIATION FOR THE TREATMENT OF HYPERTENSION AND CONGESTIVE HEART FAILURE. (CASE 100-7516)
RU98103406A (en) METHOD FOR TREATING VIBRATIONAL DISEASE
ITMI20022594A1 (en) THERAPEUTIC COMBINATION FOR THE TREATMENT OF HYPERTENSION.
RU95122486A (en) MEANS FOR TREATMENT OF TICHOUS HYPERKINESIS

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990401

Kind code of ref document: A1

Effective date: 19990401

FD1A Patent lapsed

Effective date: 20020401